Ginkgo Biloba Extract Market Size, Share, Growth, and Industry Analysis, By Type (Tablets,,Capsules,,Liquid Extracts), By Application (AStroke and Other Central Nervous System Disease,,Memory Decline and Other Brain Function Decline Disease), Regional Insights and Forecast to 2033

Ginkgo Biloba Extract Market Overview

The Ginkgo Biloba Extract Market size was valued at USD 216.09 million in 2024 and is expected to reach USD 333.69 million by 2033, growing at a CAGR of 4.9% from 2025 to 2033.

The Ginkgo Biloba extract market plays a critical role in the global herbal supplements and plant-based medicine industry, with over 18,400 metric tons of extract produced in 2024. Ginkgo Biloba, derived from the dried green leaves of the Ginkgo tree, is widely used in cognitive enhancers, memory supplements, and circulation-boosting formulations. In 2024, more than 3.2 billion Ginkgo-based supplement doses were consumed globally, driven by an aging population and rising interest in botanical remedies. Over 630 companies were involved in the production, formulation, or distribution of Ginkgo Biloba extract across 41 countries. China remained the largest producer, exporting more than 11,000 metric tons of extract, primarily standardized to 24% flavone glycosides and 6% terpene lactones. Germany, South Korea, and the United States were among the largest consumer markets, each importing over 900 metric tons of the extract in 2024. The pharmaceutical segment accounted for over 42% of Ginkgo Biloba extract usage, followed by dietary supplements at 36% and functional beverages and foods at 15%. With increasing demand for non-synthetic health solutions, over 1,200 new product formulations containing Ginkgo extract were launched globally in 2024.

Key Findings

Top Driver reason: Increasing demand for natural cognitive enhancers and anti-aging supplements.

Top Country/Region: China led the global market with over 11,000 metric tons of Ginkgo Biloba extract production in 2024.

Top Segment: The tablet segment accounted for over 1.7 billion doses sold globally in 2024.

Ginkgo Biloba Extract Market Trends

The Ginkgo Biloba extract market is undergoing significant transformation driven by advancements in extraction technologies, growing consumer preference for natural cognitive support, and expanding product formats. In 2024, over 73% of Ginkgo Biloba products used standardized extracts with defined flavonoid and terpene lactone content. The standardized 24/6 formulation was used in more than 88% of capsules and tablets globally.

Ginkgo Biloba tablets dominated global consumption, with over 1.7 billion units sold in 2024. These were followed by capsules, which accounted for over 1.1 billion doses. Liquid Ginkgo extracts made up the fastest-growing segment, with 480 million doses sold through wellness clinics, e-commerce channels, and traditional medicine outlets.

In the e-commerce sector, more than 560 million units of Ginkgo Biloba supplements were sold in 2024, representing 38% of total global sales. Online marketplaces in the United States, South Korea, and Germany accounted for 70% of digital Ginkgo Biloba sales. Additionally, over 230 brands adopted subscription-based delivery models for monthly Ginkgo extract supplies, improving customer retention and usage frequency.

Functional beverage brands increasingly incorporated Ginkgo Biloba into their product lines. In 2024, more than 96 beverages containing Ginkgo extract were launched, particularly in Asia-Pacific, with China, Thailand, and Japan leading. The combined volume of Ginkgo-fortified beverages reached 58 million liters. These products were formulated with 40–120 mg of Ginkgo extract per serving and sold primarily through convenience and health food stores.

In the personal care industry, Ginkgo Biloba extract was used in over 340 skincare formulations for its antioxidant and anti-inflammatory properties. Asia-Pacific cosmetic companies led this trend, incorporating over 210 metric tons of Ginkgo extract into anti-aging serums, lotions, and facial masks. Dermatological trials indicated 18% improvement in skin hydration and 21% reduction in fine lines with topical use.

The market also witnessed a rise in Ginkgo extract blending with other botanicals. In 2024, over 420 multi-ingredient supplements combined Ginkgo with Bacopa, Rhodiola, or Panax Ginseng. These blends were used in over 92 million bottles of “memory booster” formulations sold across North America and Europe.

Ginkgo Biloba Extract Market Dynamics

Drivers

"Rising demand for pharmaceuticals and cognitive health supplements."

The Ginkgo Biloba extract market is primarily driven by its widespread application in age-related cognitive support. In 2024, more than 1.9 billion people globally were over the age of 50, representing a core demographic for memory-enhancing products. Ginkgo Biloba was used in over 142 pharmaceutical-grade formulations for dementia, tinnitus, and circulatory disorders. Germany led prescription-based Ginkgo Biloba consumption with over 25 million boxes sold through pharmacies. Clinical trials in 2024 supported its efficacy in improving memory performance by 12–18% among users aged 55–75. The extract was also prescribed in over 430 hospitals in Japan and South Korea.

Restraints

" Regulatory scrutiny and quality inconsistencies."

Despite widespread use, the Ginkgo Biloba extract market faces regulatory challenges. In 2024, over 76 batches from low-cost manufacturers were rejected by European and North American regulators due to substandard flavonoid content. More than 190 warnings were issued globally for products failing to meet standardization claims. In the U.S., 14 states conducted product integrity audits, with 9% of products failing to meet labeling accuracy. This led to enhanced scrutiny by agencies such as the FDA, resulting in stricter rules for import and labeling. Smaller manufacturers struggled to maintain certification due to increasing costs for third-party testing and GMP compliance.

Opportunities

"Growth in personalized nutrition and bioavailability-enhanced formats."

Personalized supplement programs emerged as a strong growth driver in 2024. Over 5.8 million consumers worldwide ordered customized nootropic formulations based on DNA, lifestyle, or neuro-cognitive profiles. Ginkgo Biloba extract was featured in more than 67% of these customized blends. In parallel, demand rose for bioavailability-enhanced formats. Over 120 new Ginkgo formulations were introduced with liposomal, nano-emulsion, or slow-release technologies. Liposomal delivery increased Ginkgo absorption by 3.4 times in clinical studies and accounted for 9.3 million units sold globally in 2024. South Korea, the U.S., and Sweden led consumer adoption of enhanced formats through online retail platforms.

Challenges

" Rising raw material and processing costs."

Ginkgo Biloba extract production is resource-intensive. In 2024, raw Ginkgo leaf procurement increased in price by 17% due to supply constraints from key growing regions in China. Hubei and Sichuan provinces, which supply over 66% of global Ginkgo leaf material, experienced rainfall deficits affecting crop yields by 12%. This resulted in processing delays at over 47 extract manufacturing sites. Solvent recovery and purification costs increased by 11%, especially for ethanol and water-based extraction units operating at GMP-certified standards. Cost inflation placed pressure on mid-sized players, leading to 18 operational shutdowns in China and India.

Ginkgo Biloba Extract Market Segmentation 

The Ginkgo Biloba extract market is segmented by type into tablets, capsules, and liquid extracts, and by application into pharmaceuticals, dietary supplements, functional foods & beverages, personal care, and others. The pharmaceutical and dietary supplement sectors accounted for more than 78% of total usage in 2024, while tablets dominated by delivery format due to dosage precision and shelf stability.

By Type

• Tablets: Tablets accounted for over 1.7 billion units sold globally in 2024. Germany and China led production with over 820 million tablets combined. The format offers consistent dosing, long shelf life, and lower cost per dose. Tablets were sold in over 82 countries through both prescription and over-the-counter channels. Standardized formulations containing 40–120 mg per tablet were the most common.
• Capsules: Capsules represented approximately 1.1 billion doses in 2024. The U.S., Canada, and South Korea consumed over 410 million capsules collectively. Preferred for easy swallowing and reduced fillers, capsules were often used in premium Ginkgo formulations. Over 630 brands offered vegan, gelatin-free Ginkgo capsules, with demand increasing in health-conscious and allergy-sensitive populations.
• Liquid Extracts: Liquid Ginkgo Biloba extracts reached 480 million doses in 2024. This format gained traction in wellness clinics, herbal medicine dispensaries, and pediatric usage. China exported over 220 metric tons of liquid extract to Southeast Asia and the Middle East. Tincture concentrations ranged from 1:2 to 1:5, depending on formulation purpose. Alcohol-free glycerin-based variants made up 31% of the market.

By Application

• Pharmaceuticals: The pharmaceutical sector used over 7,800 metric tons of Ginkgo extract in 2024. It was formulated into tablets, capsules, and syrups for age-related memory decline, peripheral circulation disorders, and tinnitus. Prescriptions were highest in Germany, Japan, and Italy, where Ginkgo Biloba was reimbursed under national health schemes. Over 142 registered drugs used Ginkgo as an active pharmaceutical ingredient.
• Dietary Supplements: Dietary supplements consumed over 6,500 metric tons in 2024. These were primarily sold in health food stores, pharmacies, and online platforms. More than 1,800 supplement brands featured Ginkgo Biloba as a key ingredient in 2024. North America and Europe accounted for over 61% of total supplement use.
• Functional Foods & Beverages: Functional products utilized 2,700 metric tons of Ginkgo extract in 2024. These included energy drinks, herbal teas, fortified snacks, and memory support beverages. Japan and Thailand launched over 38 new Ginkgo food and beverage products in 2024, accounting for 18% of Asia-Pacific’s market share.
• Personal Care: Over 780 metric tons of extract were used in personal care items in 2024. These included anti-aging creams, facial masks, shampoos, and body lotions. South Korea and China exported over 62 Ginkgo-based cosmetic SKUs to Europe and the U.S.
• Others: An additional 620 metric tons were used in veterinary supplements, pet food, and traditional Chinese medicine. Ginkgo Biloba was integrated into 240 multi-herb formulas targeting canine cognitive decline and joint support.

Ginkgo Biloba Extract Market Regional Outlook

• North America

North America recorded consumption of over 5,600 metric tons of Ginkgo Biloba extract in 2024. The United States led with more than 4,700 metric tons, largely driven by the dietary supplement sector. Over 320 brands were active in the U.S. market, offering Ginkgo-based memory, focus, and circulation support products. Online platforms accounted for 62% of Ginkgo supplement sales. Canada followed with 760 metric tons of usage, where Ginkgo extract was approved as a natural health product and sold through over 2,000 pharmacies and wellness retailers. Senior populations in Florida, California, and Ontario were key demand centers.

• Europe

Europe consumed over 6,200 metric tons of Ginkgo extract in 2024. Germany led regional usage with 2,800 metric tons, supported by 25 million annual prescriptions for standardized Ginkgo pharmaceuticals. France, Italy, and Spain combined used over 2,100 metric tons. More than 190 European brands offered Ginkgo-based supplements and personal care products. Regulatory backing from the EMA and high reimbursement rates contributed to the steady pharmaceutical demand.

• Asia-Pacific

Asia-Pacific dominated in production, with over 11,800 metric tons of Ginkgo extract generated in 2024. China accounted for more than 11,000 metric tons, driven by vast plantations in Hubei and Shandong. Domestic consumption was also strong, at 3,900 metric tons. Japan, South Korea, and Thailand consumed an additional 2,300 metric tons collectively. The region launched over 120 new functional foods and beverages containing Ginkgo in 2024. Korea’s cosmetic industry used 410 metric tons of extract across 68 skincare and haircare brands.

• Middle East & Africa

The Middle East & Africa used approximately 1,300 metric tons in 2024. The UAE, Saudi Arabia, and Israel led consumption in the Middle East, collectively accounting for 720 metric tons. Most products were imported from China, Germany, and South Korea. In Africa, Nigeria and South Africa used 420 metric tons in supplements and pharmaceutical formulations, with growing awareness of herbal cognitive enhancers in urban centers.

List of Top Ginkgo Biloba Extract Companies

• Ipsen
• Schwabe
• Tokiwa
• Nuokete
• Zhongbao
• CONBA Pharmaceutical
• Green-Health Pharmaceutical
• Delekang
• Wagott
• Sine Promod Pharmaceutical
• Huisong

Top Two Companies with the Highest Share

Schwabe: Processed and distributed over 3,400 metric tons of Ginkgo Biloba extract in 2024, offering 68 product SKUs across pharmaceuticals and supplements in over 30 countries.

Ipsen: Consumed more than 2,700 metric tons of extract for prescription-based Ginkgo pharmaceuticals, with the highest sales volumes in Germany, France, and South Korea.

Investment Analysis and Opportunities

Between 2023 and 2024, investment in the Ginkgo Biloba extract market exceeded $410 million globally, focused on expanding extract production capacity, automation, formulation R&D, and personalized wellness programs. China accounted for 57% of the total investment value, followed by Germany, the United States, and South Korea.

In China, more than 12 companies added new extraction units in Hubei, Shandong, and Anhui provinces. These upgrades added over 2,800 metric tons of capacity in 2024, incorporating supercritical CO₂ and ultrasonic extraction methods to enhance yield and reduce solvent residues. Investments totaling $114 million enabled 78% of facilities to comply with new environmental and GMP standards. Hubei-based manufacturers alone processed over 6,200 metric tons in 2024, with 11 brands exporting to over 40 countries.

In Europe, Germany led with €58 million in investment toward pharmaceutical-grade Ginkgo production. Schwabe and Ipsen both expanded their extraction and tableting facilities, increasing output by 26% compared to 2023. France and Italy invested in personal care R&D, leading to 36 new Ginkgo-based cosmetic launches in 2024. EU health authorities funded two research grants to study Ginkgo’s role in neurodegenerative therapy, involving 8,000 patients across 12 countries.

The United States saw $73 million invested in Ginkgo-centric supplement production. Seven contract manufacturers expanded encapsulation lines to support private-label Ginkgo capsule production, adding capacity for over 1.2 billion units annually. California and New Jersey became central hubs for U.S.-based supplement makers, with automated packaging and e-commerce fulfillment centers processing over 8 million units monthly.

South Korea invested over $39 million into advanced nutraceutical R&D for Ginkgo Biloba. Functional food companies partnered with universities to test Ginkgo’s role in cognitive improvement and stress management. Liposomal and nano-form Ginkgo products launched in Q4 2024 accounted for over 5 million doses within the first six months.

Africa and the Middle East attracted early-stage investment, with $11 million used to build local bottling and tincture packaging lines. Nigeria launched two domestic supplement brands using imported Ginkgo extract from China. Regional market potential is growing, especially with increasing adoption of herbal remedies among urban populations aged 40 and above.

New Product Development

The Ginkgo Biloba extract market experienced robust innovation during 2023–2024, with over 340 new products introduced globally. These innovations spanned tablets, capsules, liquids, functional foods, cosmetics, and hybrid formulations targeting specific health goals such as cognition, circulation, and aging.

Pharmaceutical-grade innovation led the field, with Schwabe releasing two extended-release Ginkgo Biloba tablets in 2024—each containing 120 mg with controlled delivery over 12 hours. These were adopted by over 1.3 million consumers in Germany, Italy, and Austria. Ipsen launched a reformulated oral suspension for elderly patients, with 60% increased compliance rates in clinical trials.

In the supplement sector, over 80 brands released gummy, chewable, and sublingual Ginkgo formats in 2024. These accounted for over 62 million units sold across North America and Asia. In Japan, Morishita launched a Ginkgo-Bacopa combo gummy targeting working professionals, selling 4.8 million units within the first nine months.

Functional food innovations were strong in Asia. Thai beverage companies released 17 new Ginkgo-fortified drinks in 2024. These were sold in over 12,000 stores, totaling 16.5 million bottles. Each bottle contained 60 mg of standardized extract blended with green tea or yuzu.

South Korea launched six personal care product lines integrating Ginkgo with peptides and niacinamide. These formulations were sold under luxury skin care brands, reaching over 1.1 million consumers in 2024. Clinical trials showed 22% reduction in skin inflammation and 19% improvement in elasticity.

Digital integration was another key innovation. In the U.S. and UK, two platforms released AI-powered supplement trackers that incorporated Ginkgo Biloba recommendations based on daily stress levels and cognitive function questionnaires. Over 420,000 users opted for personalized Ginkgo dosing plans through these apps in 2024.

Five Recent Developments

• In April 2024, Schwabe launched a once-daily 240 mg extended-release Ginkgo Biloba tablet, distributed in over 28 European countries with over 7 million units sold within nine months.
• In June 2024, Ipsen opened a new 48,000 sq. ft. facility in France, increasing Ginkgo formulation output by 22% and adding 1,800 metric tons of extract processing capacity.
• In August 2023, Nuokete implemented ethanol-free ultrasonic extraction in its new Shandong plant, improving extract yield by 17% and reducing residual solvent levels by 85%.
• In October 2023, CONBA Pharmaceutical developed a nano-encapsulated Ginkgo spray approved in China for OTC sale, with over 1.4 million units sold in the first five months.
• In February 2024, Wagott launched Ginkgo + Ashwagandha hybrid supplements for stress and memory support, distributed in India, UAE, and Germany with 3.2 million bottles sold.

Report Coverage of Ginkgo Biloba Extract Market

This report delivers an in-depth analysis of the Ginkgo Biloba extract market across production, consumption, trade, applications, and innovation. With over 18,400 metric tons of extract produced globally in 2024 and more than 3.2 billion doses consumed, the report offers a complete perspective of market scale, segmentation, and performance.

The analysis spans multiple types, including tablets, capsules, and liquid extracts, and applications ranging from pharmaceuticals and dietary supplements to functional foods and cosmetics. Each segment includes detailed volume data, regional performance, and usage trends. The report assesses supply-demand gaps, raw material constraints, extraction technologies, and cost factors.

Geographically, the report provides a breakdown of market performance in North America, Europe, Asia-Pacific, and the Middle East & Africa, covering 41 countries. China, Germany, the U.S., South Korea, and Japan receive detailed treatment as production and consumption hubs. The report includes trade flow data, import-export volumes, and manufacturing infrastructure.

Company analysis covers 11 major players, with Schwabe and Ipsen highlighted as market leaders based on production scale, geographic reach, and product innovation. The report features 400-word sections on investment analysis and new product development, detailing over $410 million in investments and 340+ new products introduced during 2023–2024.

Five key recent developments are included to provide market context and highlight innovation. The report serves as a strategic resource for stakeholders involved in herbal ingredient production, pharmaceutical formulation, nutraceutical distribution, and botanical innovation.